+629.1%
MRNA vs FCEL
-93.1%
+722.2%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | FCEL | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -6.7% | +3.3% | -2.8% |
| 7D | -10.1% | +15.1% | -25.1% | -11.4% |
| 30D | +126.7% | -16.4% | +143.2% | +128.9% |
| 3M | +184.1% | -5.3% | +189.4% | +179.7% |
| 6M | +143.3% | +124.5% | +18.8% | +115.8% |
| YTD | +359.9% | +126.7% | +233.2% | +306.2% |
| 1Y | +454.2% | +219.9% | +234.3% | +367.5% |
| 3Y | +26.0% | -61.6% | +87.6% | +18.6% |
| 5Y | -70.3% | -90.5% | +20.3% | -70.2% |
| All | +629.1% | -93.1% | +722.2% | +657.0% |
Cumulative growth
Daily Returns
Daily percentage return beside FCEL.
Daily Out/Under-Performance
Portfolio return minus FCEL return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × FCEL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded FCEL wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling